Are benefits of the new Alzheimer's drug overblown?
The cost, time burden, and potential side effects of a new Alzheimer's drug may not be worth the minimal benefit, research suggests.
Source: futurity.org
Mark Ebell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Ebell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Ebell Today - Breaking & Trending Today
Study questions benefit of new Alzheimer's drug
Cost, time burden and side effects may not be worth the minimal benefit.
Source: uga.edu
Alzheimer's: The risks of monoclonal antibodies may outweigh benefits
Researchers are reporting that the risks from monoclonal antibody treatments for Alzheimer's appear to outweigh the benefits, so these therapies probably people shouldn't be used on most people with the disease
Source: medicalnewstoday.com
UGA study questions effectiveness of US FDA Alzheimer's drug | Campus News
The effectiveness of a new drug used to treat Alzheimer’s was called into question by a recent University of Georgia study, according to a Jan. 22 press release.
Source: redandblack.com
Study investigates using telemedicine for flu diagnosis
Almost a quarter of Americans now opt for a telehealth visit.
Source: uga.edu